ID   PGAM5_HUMAN             Reviewed;         289 AA.
AC   Q96HS1; A9LN06; C9IZY7; Q96JB0;
DT   29-MAY-2007, integrated into UniProtKB/Swiss-Prot.
DT   29-MAY-2007, sequence version 2.
DT   15-MAR-2017, entry version 123.
DE   RecName: Full=Serine/threonine-protein phosphatase PGAM5, mitochondrial;
DE            EC=3.1.3.16;
DE   AltName: Full=Bcl-XL-binding protein v68;
DE   AltName: Full=Phosphoglycerate mutase family member 5;
GN   Name=PGAM5;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA], IDENTIFICATION BY MASS SPECTROMETRY,
RP   ALTERNATIVE SPLICING, SUBUNIT, INTERACTION WITH BCL2L1 AND KEAP1, AND
RP   MUTAGENESIS OF GLU-79 AND SER-80.
RX   PubMed=17046835; DOI=10.1074/jbc.M606539200;
RA   Lo S.-C., Hannink M.;
RT   "PGAM5, a Bcl-XL-interacting protein, is a novel substrate for the
RT   redox-regulated Keap1-dependent ubiquitin ligase complex.";
RL   J. Biol. Chem. 281:37893-37903(2006).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=16541075; DOI=10.1038/nature04569;
RA   Scherer S.E., Muzny D.M., Buhay C.J., Chen R., Cree A., Ding Y.,
RA   Dugan-Rocha S., Gill R., Gunaratne P., Harris R.A., Hawes A.C.,
RA   Hernandez J., Hodgson A.V., Hume J., Jackson A., Khan Z.M.,
RA   Kovar-Smith C., Lewis L.R., Lozado R.J., Metzker M.L.,
RA   Milosavljevic A., Miner G.R., Montgomery K.T., Morgan M.B.,
RA   Nazareth L.V., Scott G., Sodergren E., Song X.-Z., Steffen D.,
RA   Lovering R.C., Wheeler D.A., Worley K.C., Yuan Y., Zhang Z.,
RA   Adams C.Q., Ansari-Lari M.A., Ayele M., Brown M.J., Chen G., Chen Z.,
RA   Clerc-Blankenburg K.P., Davis C., Delgado O., Dinh H.H., Draper H.,
RA   Gonzalez-Garay M.L., Havlak P., Jackson L.R., Jacob L.S., Kelly S.H.,
RA   Li L., Li Z., Liu J., Liu W., Lu J., Maheshwari M., Nguyen B.-V.,
RA   Okwuonu G.O., Pasternak S., Perez L.M., Plopper F.J.H., Santibanez J.,
RA   Shen H., Tabor P.E., Verduzco D., Waldron L., Wang Q., Williams G.A.,
RA   Zhang J., Zhou J., Allen C.C., Amin A.G., Anyalebechi V., Bailey M.,
RA   Barbaria J.A., Bimage K.E., Bryant N.P., Burch P.E., Burkett C.E.,
RA   Burrell K.L., Calderon E., Cardenas V., Carter K., Casias K.,
RA   Cavazos I., Cavazos S.R., Ceasar H., Chacko J., Chan S.N., Chavez D.,
RA   Christopoulos C., Chu J., Cockrell R., Cox C.D., Dang M.,
RA   Dathorne S.R., David R., Davis C.M., Davy-Carroll L., Deshazo D.R.,
RA   Donlin J.E., D'Souza L., Eaves K.A., Egan A., Emery-Cohen A.J.,
RA   Escotto M., Flagg N., Forbes L.D., Gabisi A.M., Garza M., Hamilton C.,
RA   Henderson N., Hernandez O., Hines S., Hogues M.E., Huang M.,
RA   Idlebird D.G., Johnson R., Jolivet A., Jones S., Kagan R., King L.M.,
RA   Leal B., Lebow H., Lee S., LeVan J.M., Lewis L.C., London P.,
RA   Lorensuhewa L.M., Loulseged H., Lovett D.A., Lucier A., Lucier R.L.,
RA   Ma J., Madu R.C., Mapua P., Martindale A.D., Martinez E., Massey E.,
RA   Mawhiney S., Meador M.G., Mendez S., Mercado C., Mercado I.C.,
RA   Merritt C.E., Miner Z.L., Minja E., Mitchell T., Mohabbat F.,
RA   Mohabbat K., Montgomery B., Moore N., Morris S., Munidasa M.,
RA   Ngo R.N., Nguyen N.B., Nickerson E., Nwaokelemeh O.O., Nwokenkwo S.,
RA   Obregon M., Oguh M., Oragunye N., Oviedo R.J., Parish B.J.,
RA   Parker D.N., Parrish J., Parks K.L., Paul H.A., Payton B.A., Perez A.,
RA   Perrin W., Pickens A., Primus E.L., Pu L.-L., Puazo M., Quiles M.M.,
RA   Quiroz J.B., Rabata D., Reeves K., Ruiz S.J., Shao H., Sisson I.,
RA   Sonaike T., Sorelle R.P., Sutton A.E., Svatek A.F., Svetz L.A.,
RA   Tamerisa K.S., Taylor T.R., Teague B., Thomas N., Thorn R.D.,
RA   Trejos Z.Y., Trevino B.K., Ukegbu O.N., Urban J.B., Vasquez L.I.,
RA   Vera V.A., Villasana D.M., Wang L., Ward-Moore S., Warren J.T.,
RA   Wei X., White F., Williamson A.L., Wleczyk R., Wooden H.S.,
RA   Wooden S.H., Yen J., Yoon L., Yoon V., Zorrilla S.E., Nelson D.,
RA   Kucherlapati R., Weinstock G., Gibbs R.A.;
RT   "The finished DNA sequence of human chromosome 12.";
RL   Nature 440:346-351(2006).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 2).
RC   TISSUE=Cervix;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [MRNA] OF 124-157.
RC   TISSUE=Kidney;
RX   PubMed=11283018; DOI=10.1074/jbc.M011641200;
RA   Hammond P.W., Alpin J., Rise C.E., Wright M., Kreider B.L.;
RT   "In vitro selection and characterization of Bcl-X(L)-binding proteins
RT   from a mix of tissue-specific mRNA display libraries.";
RL   J. Biol. Chem. 276:20898-20906(2001).
RN   [5]
RP   IDENTIFICATION BY MASS SPECTROMETRY, SUBUNIT, INTERACTION WITH NFE2L2
RP   AND KEAP1, FUNCTION, AND SUBCELLULAR LOCATION.
RX   PubMed=18387606; DOI=10.1016/j.yexcr.2008.02.014;
RA   Lo S.-C., Hannink M.;
RT   "PGAM5 tethers a ternary complex containing Keap1 and Nrf2 to
RT   mitochondria.";
RL   Exp. Cell Res. 314:1789-1803(2008).
RN   [6]
RP   FUNCTION, INTERACTION WITH MAP3K5, AND MUTAGENESIS OF HIS-105.
RX   PubMed=19590015; DOI=10.1073/pnas.0901823106;
RA   Takeda K., Komuro Y., Hayakawa T., Oguchi H., Ishida Y., Murakami S.,
RA   Noguchi T., Kinoshita H., Sekine Y., Iemura S., Natsume T., Ichijo H.;
RT   "Mitochondrial phosphoglycerate mutase 5 uses alternate catalytic
RT   activity as a protein serine/threonine phosphatase to activate ASK1.";
RL   Proc. Natl. Acad. Sci. U.S.A. 106:12301-12305(2009).
RN   [7]
RP   ACETYLATION [LARGE SCALE ANALYSIS] AT LYS-116; LYS-144 AND LYS-191,
RP   AND IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=19608861; DOI=10.1126/science.1175371;
RA   Choudhary C., Kumar C., Gnad F., Nielsen M.L., Rehman M.,
RA   Walther T.C., Olsen J.V., Mann M.;
RT   "Lysine acetylation targets protein complexes and co-regulates major
RT   cellular functions.";
RL   Science 325:834-840(2009).
RN   [8]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21269460; DOI=10.1186/1752-0509-5-17;
RA   Burkard T.R., Planyavsky M., Kaupe I., Breitwieser F.P.,
RA   Buerckstuemmer T., Bennett K.L., Superti-Furga G., Colinge J.;
RT   "Initial characterization of the human central proteome.";
RL   BMC Syst. Biol. 5:17-17(2011).
RN   [9]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-80, AND IDENTIFICATION
RP   BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21406692; DOI=10.1126/scisignal.2001570;
RA   Rigbolt K.T., Prokhorova T.A., Akimov V., Henningsen J.,
RA   Johansen P.T., Kratchmarova I., Kassem M., Mann M., Olsen J.V.,
RA   Blagoev B.;
RT   "System-wide temporal characterization of the proteome and
RT   phosphoproteome of human embryonic stem cell differentiation.";
RL   Sci. Signal. 4:RS3-RS3(2011).
RN   [10]
RP   FUNCTION, IDENTIFICATION IN COMPLEX WITH RIPK1; RIPK3 AND MLKL, AND
RP   INTERACTION WITH DNM1L.
RX   PubMed=22265414; DOI=10.1016/j.cell.2011.11.030;
RA   Wang Z., Jiang H., Chen S., Du F., Wang X.;
RT   "The mitochondrial phosphatase PGAM5 functions at the convergence
RT   point of multiple necrotic death pathways.";
RL   Cell 148:228-243(2012).
RN   [11]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-80 AND SER-87, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Erythroleukemia;
RX   PubMed=23186163; DOI=10.1021/pr300630k;
RA   Zhou H., Di Palma S., Preisinger C., Peng M., Polat A.N., Heck A.J.,
RA   Mohammed S.;
RT   "Toward a comprehensive characterization of a human cancer cell
RT   phosphoproteome.";
RL   J. Proteome Res. 12:260-271(2013).
RN   [12]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=25944712; DOI=10.1002/pmic.201400617;
RA   Vaca Jacome A.S., Rabilloud T., Schaeffer-Reiss C., Rompais M.,
RA   Ayoub D., Lane L., Bairoch A., Van Dorsselaer A., Carapito C.;
RT   "N-terminome analysis of the human mitochondrial proteome.";
RL   Proteomics 15:2519-2524(2015).
RN   [13]
RP   X-RAY CRYSTALLOGRAPHY (1.7 ANGSTROMS) OF 90-289.
RG   Structural genomics consortium (SGC);
RT   "Crystal structure of human phosphoglycerate mutase family member 5
RT   (PGAM5).";
RL   Submitted (SEP-2010) to the PDB data bank.
CC   -!- FUNCTION: Displays phosphatase activity for serine/threonine
CC       residues, and, dephosphorylates and activates MAP3K5 kinase. Has
CC       apparently no phosphoglycerate mutase activity. May be regulator
CC       of mitochondrial dynamics. Substrate for a KEAP1-dependent
CC       ubiquitin ligase complex. Contributes to the repression of NFE2L2-
CC       dependent gene expression. Acts as a central mediator for
CC       programmed necrosis induced by TNF, by reactive oxygen species and
CC       by calcium ionophore. {ECO:0000269|PubMed:18387606,
CC       ECO:0000269|PubMed:19590015, ECO:0000269|PubMed:22265414}.
CC   -!- CATALYTIC ACTIVITY: [a protein]-serine/threonine phosphate + H(2)O
CC       = [a protein]-serine/threonine + phosphate.
CC   -!- SUBUNIT: Dimer. Forms a ternary complex with NFE2L2 and KEAP1.
CC       Interacts with BCL2L1 and MAP3K5. Upon TNF-induced necrosis, forms
CC       in complex with RIPK1, RIPK3 and MLKL; the formation of this
CC       complex leads to PGAM5 phosphorylation. Isoform 2, but not isoform
CC       1, interacts with DNM1L; this interaction leads to DNM1L
CC       dephosphorylation and activation and eventually to mitochondria
CC       fragmentation. {ECO:0000269|PubMed:17046835,
CC       ECO:0000269|PubMed:18387606, ECO:0000269|PubMed:19590015,
CC       ECO:0000269|PubMed:22265414}.
CC   -!- SUBCELLULAR LOCATION: Mitochondrion outer membrane
CC       {ECO:0000269|PubMed:18387606}; Single-pass membrane protein
CC       {ECO:0000269|PubMed:18387606}. Note=Isoform 2 overexpression
CC       results in the formation of disconnected punctuate mitochondria
CC       distributed throughout the cytoplasm. Isoform 1 overexpression
CC       results in the clustering of mitochondria around the nucleus.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=2;
CC       Name=1; Synonyms=PGAM5-L;
CC         IsoId=Q96HS1-1; Sequence=Displayed;
CC       Name=2; Synonyms=PGAM5-S;
CC         IsoId=Q96HS1-2; Sequence=VSP_025761;
CC         Note=Ref.2 (AAH08196) sequence is in conflict in position:
CC         252:L->V. {ECO:0000305};
CC   -!- DOMAIN: The N-terminal 35 amino acids, including the potential
CC       transmembrane alpha-helix, function as a non-cleaved mitochondrial
CC       targeting sequence that targets the protein to the cytosolic side
CC       of the outer mitochondrial membrane.
CC       {ECO:0000269|PubMed:18387606}.
CC   -!- PTM: Both isoform 1 and isoform 2 are phosphorylated by the
CC       RIPK1/RIPK3 complex under necrotic conditions. This
CC       phosphorylation increases PGAM5 phosphatase activity.
CC   -!- SIMILARITY: Belongs to the phosphoglycerate mutase family. BPG-
CC       dependent PGAM subfamily. {ECO:0000305}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; EU249757; ABX39494.1; -; mRNA.
DR   EMBL; AC135586; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; BC008196; AAH08196.1; -; mRNA.
DR   EMBL; AF357523; AAK60627.1; -; mRNA.
DR   CCDS; CCDS53845.1; -. [Q96HS1-1]
DR   CCDS; CCDS9280.1; -. [Q96HS1-2]
DR   RefSeq; NP_001164014.1; NM_001170543.1. [Q96HS1-1]
DR   RefSeq; NP_612642.2; NM_138575.3. [Q96HS1-2]
DR   UniGene; Hs.102558; -.
DR   PDB; 3MXO; X-ray; 1.70 A; A/B=90-289.
DR   PDB; 3O0T; X-ray; 1.90 A; A/B=90-289.
DR   PDBsum; 3MXO; -.
DR   PDBsum; 3O0T; -.
DR   ProteinModelPortal; Q96HS1; -.
DR   SMR; Q96HS1; -.
DR   BioGrid; 128154; 60.
DR   DIP; DIP-50735N; -.
DR   IntAct; Q96HS1; 41.
DR   MINT; MINT-1385191; -.
DR   STRING; 9606.ENSP00000438465; -.
DR   DEPOD; Q96HS1; -.
DR   iPTMnet; Q96HS1; -.
DR   PhosphoSitePlus; Q96HS1; -.
DR   SwissPalm; Q96HS1; -.
DR   BioMuta; PGAM5; -.
DR   DMDM; 150417955; -.
DR   EPD; Q96HS1; -.
DR   MaxQB; Q96HS1; -.
DR   PaxDb; Q96HS1; -.
DR   PeptideAtlas; Q96HS1; -.
DR   PRIDE; Q96HS1; -.
DR   TopDownProteomics; Q96HS1-1; -. [Q96HS1-1]
DR   TopDownProteomics; Q96HS1-2; -. [Q96HS1-2]
DR   Ensembl; ENST00000317555; ENSP00000321503; ENSG00000247077. [Q96HS1-2]
DR   Ensembl; ENST00000498926; ENSP00000438465; ENSG00000247077. [Q96HS1-1]
DR   GeneID; 192111; -.
DR   KEGG; hsa:192111; -.
DR   UCSC; uc001uku.4; human. [Q96HS1-1]
DR   CTD; 192111; -.
DR   GeneCards; PGAM5; -.
DR   H-InvDB; HIX0017319; -.
DR   HGNC; HGNC:28763; PGAM5.
DR   HPA; CAB068215; -.
DR   HPA; HPA036978; -.
DR   HPA; HPA036979; -.
DR   MIM; 614939; gene.
DR   neXtProt; NX_Q96HS1; -.
DR   OpenTargets; ENSG00000247077; -.
DR   PharmGKB; PA143485574; -.
DR   eggNOG; KOG4609; Eukaryota.
DR   eggNOG; ENOG410XXCQ; LUCA.
DR   GeneTree; ENSGT00390000004796; -.
DR   HOGENOM; HOG000261217; -.
DR   HOVERGEN; HBG105576; -.
DR   InParanoid; Q96HS1; -.
DR   KO; K15637; -.
DR   OMA; KEDSYEI; -.
DR   OrthoDB; EOG091G0DEJ; -.
DR   PhylomeDB; Q96HS1; -.
DR   TreeFam; TF314977; -.
DR   ChiTaRS; PGAM5; human.
DR   EvolutionaryTrace; Q96HS1; -.
DR   GenomeRNAi; 192111; -.
DR   PRO; PR:Q96HS1; -.
DR   Proteomes; UP000005640; Chromosome 12.
DR   Bgee; ENSG00000247077; -.
DR   CleanEx; HS_PGAM5; -.
DR   ExpressionAtlas; Q96HS1; baseline and differential.
DR   Genevisible; Q96HS1; HS.
DR   GO; GO:0016021; C:integral component of membrane; IEA:UniProtKB-KW.
DR   GO; GO:0005741; C:mitochondrial outer membrane; IEA:UniProtKB-SubCell.
DR   GO; GO:0005739; C:mitochondrion; IDA:HPA.
DR   GO; GO:0005096; F:GTPase activator activity; IMP:UniProtKB.
DR   GO; GO:0016791; F:phosphatase activity; IMP:UniProtKB.
DR   GO; GO:0032403; F:protein complex binding; IDA:UniProtKB.
DR   GO; GO:0009400; F:signal transducer, downstream of receptor, with serine/threonine phosphatase activity; IDA:CACAO.
DR   GO; GO:0070266; P:necroptotic process; IMP:UniProtKB.
DR   CDD; cd07067; HP_PGM_like; 1.
DR   Gene3D; 3.40.50.1240; -; 1.
DR   InterPro; IPR013078; His_Pase_superF_clade-1.
DR   InterPro; IPR029033; His_PPase_superfam.
DR   Pfam; PF00300; His_Phos_1; 1.
DR   SMART; SM00855; PGAM; 1.
DR   SUPFAM; SSF53254; SSF53254; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Acetylation; Alternative splicing; Complete proteome;
KW   Hydrolase; Membrane; Mitochondrion; Mitochondrion outer membrane;
KW   Necrosis; Phosphoprotein; Reference proteome; Transmembrane;
KW   Transmembrane helix.
FT   CHAIN         1    289       Serine/threonine-protein phosphatase
FT                                PGAM5, mitochondrial.
FT                                /FTId=PRO_0000288782.
FT   TRANSMEM      7     29       Helical. {ECO:0000255}.
FT   REGION       77     82       Interaction with KEAP1.
FT   MOD_RES      80     80       Phosphoserine.
FT                                {ECO:0000244|PubMed:21406692,
FT                                ECO:0000244|PubMed:23186163}.
FT   MOD_RES      87     87       Phosphoserine.
FT                                {ECO:0000244|PubMed:23186163}.
FT   MOD_RES     116    116       N6-acetyllysine.
FT                                {ECO:0000244|PubMed:19608861}.
FT   MOD_RES     144    144       N6-acetyllysine.
FT                                {ECO:0000244|PubMed:19608861}.
FT   MOD_RES     191    191       N6-acetyllysine.
FT                                {ECO:0000244|PubMed:19608861}.
FT   VAR_SEQ     240    289       RALQFPPEGWLRLSLNNGSITHLVIRPNGRVALRTLGDTGF
FT                                MPPDKITRS -> SIPPLLSAGDFVLLGS (in isoform
FT                                2). {ECO:0000303|PubMed:15489334}.
FT                                /FTId=VSP_025761.
FT   MUTAGEN      79     79       E->A: Loss of interaction with KEAP1;
FT                                when associated with A-80.
FT                                {ECO:0000269|PubMed:17046835}.
FT   MUTAGEN      80     80       S->A: Loss of interaction with KEAP1;
FT                                when associated with A-79.
FT                                {ECO:0000269|PubMed:17046835}.
FT   MUTAGEN     105    105       H->A: Loss of phosphatase activity.
FT                                {ECO:0000269|PubMed:19590015}.
FT   CONFLICT    124    124       G -> C (in Ref. 3; AAK60627).
FT                                {ECO:0000305}.
FT   STRAND       98    104       {ECO:0000244|PDB:3MXO}.
FT   HELIX       115    117       {ECO:0000244|PDB:3MXO}.
FT   HELIX       122    136       {ECO:0000244|PDB:3MXO}.
FT   STRAND      143    150       {ECO:0000244|PDB:3MXO}.
FT   HELIX       151    162       {ECO:0000244|PDB:3MXO}.
FT   STRAND      169    172       {ECO:0000244|PDB:3MXO}.
FT   HELIX       173    175       {ECO:0000244|PDB:3MXO}.
FT   HELIX       197    211       {ECO:0000244|PDB:3MXO}.
FT   STRAND      223    229       {ECO:0000244|PDB:3MXO}.
FT   HELIX       231    241       {ECO:0000244|PDB:3MXO}.
FT   HELIX       246    251       {ECO:0000244|PDB:3MXO}.
FT   STRAND      259    264       {ECO:0000244|PDB:3MXO}.
FT   STRAND      270    277       {ECO:0000244|PDB:3MXO}.
FT   HELIX       283    285       {ECO:0000244|PDB:3MXO}.
SQ   SEQUENCE   289 AA;  32004 MW;  EE20D2F0A99FCD83 CRC64;
     MAFRQALQLA ACGLAGGSAA VLFSAVAVGK PRAGGDAEPR PAEPPAWAGG ARPGPGVWDP
     NWDRREPLSL INVRKRNVES GEEELASKLD HYKAKATRHI FLIRHSQYHV DGSLEKDRTL
     TPLGREQAEL TGLRLASLGL KFNKIVHSSM TRAIETTDII SRHLPGVCKV STDLLREGAP
     IEPDPPVSHW KPEAVQYYED GARIEAAFRN YIHRADARQE EDSYEIFICH ANVIRYIVCR
     ALQFPPEGWL RLSLNNGSIT HLVIRPNGRV ALRTLGDTGF MPPDKITRS
//
